Medical News

A Texas periodontist is championing a laser procedure to correct chronic periodontitis, inflammation in the gums as a result of dental plaque.

Results of a recent international study published in The New England Journal of Medicine (NEJM) suggest that plasma-derived factor VIII (pdFVIII) products and recombinant factor VIII (rFVIII) products used to treat hemophilia A are associated with similar rates of inhibitor development. 

A team of researchers from the University of Michigan (U-M) in Ann Arbor and other universities recently published a study in which they described their discovery of part of the human genome responsible for regulating von Willebrand factor (VWF) levels.

In January, Penn Medicine announced its union with the Children's Hospital of Philadelphia (CHOP) to establish the Penn-CHOP Blood Center for Patient Care and Discovery, which is being positioned as that region's first dedicated center for the treatment and research of blood diseases.

A group of expert providers, patient advocates and government health officials is working to establish a common nomenclature to ensure consistency in the measurement of a patient’s reaction (virologic response) to new hepatitis C (HCV) drugs.

Investigators from the University of Michigan (U-M) in Ann Arbor have created six new embryonic stem cell lines for US-based research. Two of the new lines carry the genetic mutation linked to hemophilia B, the first of its kind.

Results from a new study suggest that current postpartum strategies do not adequately boost von Willebrand factor (VWF) levels, contributing to potential postpartum hemorrhage in women with von Willebrand disease (VWD). 

A study published last month suggests that researchers at the University of California Los Angeles (UCLA) may have found a way to enlist genetically engineered human blood stem cells in the fight against HIV.